Inactive Instrument
Company Cognetivity Neurosciences Ltd. Canadian Securities Exchange
Stocks
CGN
CA19243C1005
Advanced Medical Equipment & Technology
Business description: Cognetivity Neurosciences Ltd.
Sales by Activity: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
Development of The ICA Platform | - | - | - | - | 45.37K |
Geographical breakdown of sales: Cognetivity Neurosciences Ltd.
| Fiscal Period: January | 2019 (CAD) | 2020 (CAD) | 2021 (CAD) | 2022 (CAD) | 2023 (CAD) |
|---|---|---|---|---|---|
United Kingdom | - | - | - | - | 45.37K |
Executive Committee: Cognetivity Neurosciences Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 2013-03-31 |
Mark Phillips
CMP | Compliance Officer | 67 | 2017-12-20 |
Composition of the Board of Directors: Cognetivity Neurosciences Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 2016-12-31 |
Mark Phillips
BRD | Director/Board Member | 67 | 2017-12-20 |
Company details: Cognetivity Neurosciences Ltd.
Medical Software & Technology Services
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +1.13% | -3.70% | +26.19% | 42.89B | |
| +2.37% | +1.63% | -43.77% | +130.73% | 12.32B | |
| +2.38% | +5.83% | -3.34% | +95.08% | 5.8B | |
| +2.63% | +6.21% | +58.78% | - | 4.2B | |
| +9.18% | +10.31% | - | - | 2.01B | |
| +0.59% | -3.03% | +0.93% | -41.28% | 1.48B | |
| -0.60% | -3.93% | -39.62% | - | 1.02B | |
| +0.40% | -1.93% | +15.23% | +148.53% | 999M | |
| -3.37% | -4.97% | +32.16% | +44.38% | 908M | |
| Average | +1.46% | -0.13% | +2.08% | +67.27% | 7.96B | |
| Weighted average by Cap. | +0.72% | +1.16% | -6.68% | +53.00% |
